Digital pathology: the value is clear.
The weight of the cancer burden spreads across patients, pathologists, oncologists, IT managers and healthcare organizations as a whole.
Consider that 9% of breast cancer surgical plans are changed when the care team meets together to review the patient treatment planning and 10% of breast cancer cases result in surgical treatment changes after a second pathologist opinion.1, 2
Without digital tools, it can be time-consuming, difficult or inefficient to share slides and seek second opinions that have been shown to improve patient outcomes. In addition, by deploying Integrated Delivery Networks – with a centralized lab and distributed pathologists – a 25% reduction in FTE cost per slide is possible.4 Digital slide sharing makes this possible by facilitating level loading of cases among generalists and subspecialists.
Transitioning from analog pathology to digital pathology can help positively impact patients and the entire cancer care team in profound, measurable ways.
Digital Pathology Outcomes*
Digital pathology helps lay the foundation for the future of more integrated and accountable care, and it can deliver powerful benefits in the near term—on a global, departmental and patient level. With the backbone of digital pathology, healthcare organizations will have the tools to help take on the looming challenge of cancer.
- Newman EA, Guest AB, Helvie MA, et al. Changes in surgical management resulting from case review of a breast cancer multidisciplinary tumor board. Cancer. 2006;107:2346-2351.
- Romanoff, et al. Breast Pathology Review: Does It Make a Difference? Annals of Surgical Oncology. Published 24 May 2014.
- Stratman C, Ho J. Digital pathology in the clinical workflow. A Time and Motion Study [abstract]. San Diego, CA: Pathology Visions; 2010.
- Report of the Second Phase of the Review of NHS Pathology Services in England, Chaired by Lord Carter of Coles.
- Kaplan, KJ. Empowering Patients with Digital Pathology. Digital Pathology Blog. September 23, 2014. http://tissuepathology.com/2014/09/23/empoweringpatients-with-digital-pathology/.
*Curtis Stratman is an employee of Omnyx, LLC. Jonhan Ho, MD, is employed by an affiliate of UPMC, which owns one half of Omnyx, LLC. Dr. Ho has received research funding from Omnyx, LLC through the University of Pittsburgh, and has the right to receive proceeds from the sale of Omnyx or its products. Dr. Ho also serves as a consultant to Omnyx, LLC, through an agreement with the University of Pittsburgh Physicians Department of Dermatology.
*The results expressed in this document may not be applicable to a particular site or installation and individual results may vary. This website and its content are provided to you for informational purposes only and do not constitute a representation, warranty or performance guarantee from Omnyx or GE Healthcare.